Catheter
- UID
- IMP/MD/2019/000050_5513d03dcf1e33d1e561f487a535dd4f_9e8b65cd0ff84db19b75bfbf8c870548
- Device class
- Class D
- Brand name
- Onyx TruCor Zotarolimus-Eluting Coronary Stent System
- License holder
- India Medtronic Private Limited
- Approving authority
- CDSCO
- Product information
- The Prevail Paclitaxel-coated PTCA Balloon Catheter is intended for Percutaneous Transluminal Coronary Angioplasty (Onyx TruCor Zotarolimus-Eluting Coronary Stent System) in the coronary arteries with a vessel diameter from 2.0 mm to 4.0 mm to treat de novo lesions, in-stent restenosis (Onyx TruCor Zotarolimus-Eluting Coronary Stent System), and small vessel disease (Onyx TruCor Zotarolimus-Eluting Coronary Stent System)
Catheter is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000050_5513d03dcf1e33d1e561f487a535dd4f_9e8b65cd0ff84db19b75bfbf8c870548. This device is marketed under the brand name Onyx TruCor Zotarolimus-Eluting Coronary Stent System. The license holder is India Medtronic Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.